Family Intervention for Mental Illness and Substance Abuse

NCT ID: NCT00043693

Last Updated: 2012-08-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

108 participants

Study Classification

INTERVENTIONAL

Study Start Date

2002-04-30

Study Completion Date

2008-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will evaluate a family intervention program for individuals with bipolar disorder, schizophrenia, or schizoaffective disorder and co-occurring substance use disorders.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Substance use disorder (SUD) in persons with severe mental illness may worsen the course of psychiatric illness. The loss of family support for individuals with mental illness is a major contributing factor to housing instability, homelessness, and other problems. Despite progress toward integrating mental health and substance abuse services, interventions that improve the course of mental illness while helping the families of the mentally ill are not currently available. Enhancing skills for coping with mental illness may be an effective strategy for treating SUD, decreasing caregiver burden, and improving the long-term outcomes for people with mental illness.

Patients and their families are randomly assigned to either the Family Intervention for Dual Diagnosis (FIDD) program or family psychoeducation. The FIDD program lasts for up to 3 years and includes both single and multiple-family group formats. The family psychoeducation program consists of 6 weekly sessions. Routine assessments are conducted on all patients, and relatives are evaluated on a wide range of outcomes, including substance abuse, hospitalizations, psychiatric symptoms, legal problems, aggression, housing and homelessness, family burden, social support, and quality of life. To determine the effectiveness of the FIDD program, knowledge of mental illness and problem-solving skills are assessed in the families following treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Schizophrenia Bipolar Disorder Substance-related Disorders

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Psychotic Disorders Schizoaffective Disorder Substance Abuse

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Participants will undergo the Family Intervention for Dual Diagnosis (FIDD) program.

Group Type EXPERIMENTAL

Family Intervention for Dual Diagnosis

Intervention Type BEHAVIORAL

The family intervention for dual diagnosis program lasts for up to 3 years and includes both single and multiple-family group formats.

2

Participants will be placed in a family psychoeducation program.

Group Type ACTIVE_COMPARATOR

Family psychoeducation program

Intervention Type BEHAVIORAL

The family psychoeducation program consists of 6 weekly sessions.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Family Intervention for Dual Diagnosis

The family intervention for dual diagnosis program lasts for up to 3 years and includes both single and multiple-family group formats.

Intervention Type BEHAVIORAL

Family psychoeducation program

The family psychoeducation program consists of 6 weekly sessions.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have schizophrenia, schizoaffective disorder, or bipolar disorder
* Have a current substance use disorder (within the past 6 months)
* Are willing to have at least 4 hours of contact per week with family members or significant others
* Plan to remain in the community
* Have family members or significant others who consent to participate in the study and plan to remain in the community
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Mental Health (NIMH)

NIH

Sponsor Role collaborator

Dartmouth-Hitchcock Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kim T. Mueser, PhD

Role: PRINCIPAL_INVESTIGATOR

Dartmouth-Hitchcock Medical Center

Shirley Glynn, PhD

Role: PRINCIPAL_INVESTIGATOR

University of California, Los Angeles

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pacific Clinics El Camino

Santa Fe Springs, California, United States

Site Status

North Suffolk Mental Health Association

Chelsea, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Mueser KT, Fox L. A family intervention program for dual disorders. Community Ment Health J. 2002 Jun;38(3):253-70. doi: 10.1023/a:1015271908765.

Reference Type BACKGROUND
PMID: 12046678 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01MH062629

Identifier Type: NIH

Identifier Source: secondary_id

View Link

DSIR SE-CE

Identifier Type: -

Identifier Source: secondary_id

R01MH062629

Identifier Type: NIH

Identifier Source: org_study_id

View Link